HIV-1 resistance mutations and plasma RNA during zidovudine plus zalcitabine combination therapy

被引：0
|
作者：
Sylvester, A
Caliendo, A
An, D
Savara, A
Byington, R
Strick, D
Lillaney, R
Sutton, L
Sepkowitz, K
Fischl, M
Simon, G
Lalezari, J
Mitsuyasu, R
DAquila, R
机构：
[1] NEW YORK HOSP,NEW YORK,NY 10021
[2] UNIV MIAMI,MIAMI,FL 33152
[3] WASHINGTON UNIV,ST LOUIS,MO
[4] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
[5] UNIV CALIF LOS ANGELES,LOS ANGELES,CA
[6] MASSACHUSETTS GEN HOSP,BOSTON,MA 02114
[7] HARVARD UNIV,SCH MED,BOSTON,MA
来源：
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1995年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [1] Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations
    Izopet, J
    Sailler, L
    Sandres, K
    Pasquier, C
    Bonnet, E
    Aquilina, C
    Puel, J
    Massip, P
    Marchou, B
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1999, 57 (02) : 163 - 168
  • [2] IN HIV-INFECTED INDIVIDUALS WHO DESIRE COMBINATION ANTIVIRAL THERAPY, ZIDOVUDINE PLUS DIDANOSINE IS PREFERRED TO ZIDOVUDINE PLUS ZALCITABINE
    MONTANER, JSG
    WAINBERG, MA
    OSHAUGHNESSY, MV
    [J]. REVIEWS IN MEDICAL VIROLOGY, 1994, 4 (01) : 9 - 12
  • [3] IN HIV-INFECTED INDIVIDUALS WHO DESIRE COMBINATION ANTIVIRAL THERAPY, ZIDOVUDINE PLUS ZALCITABINE IS PREFERRED TO ZIDOVUDINE PLUS DIDANOSINE
    CARR, A
    COOPER, DA
    [J]. REVIEWS IN MEDICAL VIROLOGY, 1994, 4 (01) : 5 - 8
  • [4] ZALCITABINE COMPARED WITH ZIDOVUDINE IN PATIENTS WITH ADVANCED HIV-1 INFECTION WHO RECEIVED PREVIOUS ZIDOVUDINE THERAPY
    FISCHL, MA
    OLSON, RM
    FOLLANSBEE, SE
    LALEZARI, JP
    HENRY, DH
    FRAME, PT
    REMICK, SC
    SALGO, MP
    LIN, AH
    NAUSSKAROL, C
    LIEBERMAN, J
    SOO, WJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (10) : 762 - 769
  • [5] The development of resistance of HIV-1 to zalcitabine
    Craig, C
    Moyle, G
    [J]. AIDS, 1997, 11 (03) : 271 - 279
  • [6] LONG-TERM PERSISTENCE OF ZIDOVUDINE-RESISTANCE MUTATIONS IN THE PLASMA HIV-1 OF PATIENTS REMOVED FROM ZIDOVUDINE THERAPY
    SMITH, MS
    KOERBER, KL
    PAGANO, JS
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 23 - 23
  • [7] ZIDOVUDINE RESISTANCE AND HIV-1 DISEASE PROGRESSION DURING ANTIRETROVIRAL THERAPY
    DAQUILA, RT
    JOHNSON, VA
    WELLES, SL
    JAPOUR, AJ
    KURITZKES, DR
    DEGRUTTOLA, V
    REICHELDERFER, PS
    COOMBS, RW
    CRUMPACKER, CS
    KAHN, JO
    RICHMAN, DD
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 122 (06) : 401 - 408
  • [8] Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy
    Pellegrin, I
    Segondy, M
    Garrigue, I
    Izopet, J
    Montes, B
    Pellegrin, JL
    Reynes, J
    Massip, P
    Puel, J
    Fleury, H
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (05) : 465 - 466
  • [9] Pattern of drug resistance mutations during combination therapy with AZT and zalcitabine didanosine
    Sitbon, G
    Albert, J
    Aperia, K
    Hurtig, M
    Johansson, C
    Moberg, C
    Holmberg, V
    Sandstrom, E
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 30 - 30
  • [10] COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE COMPARED WITH ZIDOVUDINE ALONE IN HIV-1 INFECTION
    COLLIER, AC
    COOMBS, RW
    FISCHL, MA
    SKOLNIK, PR
    NORTHFELT, D
    BOUTIN, P
    HOOPER, CJ
    KAPLAN, LD
    VOLBERDING, PA
    DAVIS, LG
    HENRARD, DR
    WELLER, S
    COREY, L
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) : 786 - 793
12345